Does OFATUMUMAB Cause Hyperhidrosis? 353 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 353 reports of Hyperhidrosis have been filed in association with OFATUMUMAB (ARZERRA). This represents 1.2% of all adverse event reports for OFATUMUMAB.
353
Reports of Hyperhidrosis with OFATUMUMAB
1.2%
of all OFATUMUMAB reports
3
Deaths
34
Hospitalizations
How Dangerous Is Hyperhidrosis From OFATUMUMAB?
Of the 353 reports, 3 (0.8%) resulted in death, 34 (9.6%) required hospitalization, and 7 (2.0%) were considered life-threatening.
Is Hyperhidrosis Listed in the Official Label?
Yes, Hyperhidrosis is listed as a known adverse reaction in the official FDA drug label for OFATUMUMAB.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Hyperhidrosis?
DULOXETINE (4,101)
ADALIMUMAB (2,745)
SODIUM (2,444)
VENLAFAXINE (1,932)
LEVOTHYROXINE (1,856)
ACETAMINOPHEN (1,578)
ETANERCEPT (1,521)
MORPHINE (1,438)
GABAPENTIN (1,408)
PREGABALIN (1,385)
Which OFATUMUMAB Alternatives Have Lower Hyperhidrosis Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB